Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Grant or award Director acquired 99 shares (grant or award)
  2. 4 Planned sale EVP Research & Development sold 2,000 shares at $60.56 ($121,120)
  3. 4 Planned sale Director sold 6,757 shares at $60.00 ($405,420)
  4. 4 Planned sale President & CEO sold 5,000 shares at $55.05 ($275,250)
  5. 4 Planned sale Director sold 6,695 shares at $55.08 ($368,761)
  6. 4 Planned sale EVP Research & Development sold 2,000 shares at $49.28 ($98,560)
  7. 4 Planned sale President & CEO sold 5,000 shares at $49.77 ($248,850)
  8. 4 Planned sale EVP Research & Development sold 2,000 shares at $51.29 ($102,580)
  9. 4 Planned sale Director sold 6,756 shares at $50.00 ($337,800)
  10. 4 Planned sale Director sold 2,150 shares at $48.67 ($104,641)
  11. 4 Planned sale President & CEO sold 5,000 shares at $48.76 ($243,800)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Planned sale EVP Research & Development sold 2,000 shares at $38.31 ($76,620)
  15. 4 Planned sale President & CEO sold 5,000 shares at $38.42 ($192,100)
  16. 4 Planned sale EVP Research & Development sold 2,000 shares at $36.34 ($72,680)
  17. 4 Planned sale President & CEO sold 5,000 shares at $36.45 ($182,250)
  18. 4 Planned sale EVP Research & Development sold 2,000 shares at $37.47 ($74,940)
  19. 4 Grant or award Director acquired 559 shares (grant or award)
  20. 4 Grant or award Director acquired 164 shares (grant or award)

Page 8 of 70 · 1,399 filings